To more directly address whether inhibition of protein translation contributes to MCL-1 downregulation following MLN8237 treatment, we first measured the effects of MLN8237 on global protein translation in MYCN-amplified neuroblastoma cells (Goodman et al., 2011). The gene discussed is MYCN; the disease is neuroblastoma.